Evidence map›Paper›PMID 40723451›Full record

ArticleBiology2025

TLR4 Asp299Gly SNP (rs4986790) Protects from Periodontal Inflammatory Destruction by Altering TLR4 Susceptibility to LPS Stimulation.

Franco Cavalla, Claudia C Biguetti, Ariadne Letra, Renato M Silva, Alexandre R Vieira, Franz J Strauss, Gustavo P Garlet

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Franco CavallaSchool of Dentistry, University Andres Bello, Santiago 7590924, Chile.
Claudia C BiguettiBauru School of Dentistry, University of Sao Paulo, Bauru 14040-902, Brazil.ORCID 0000-0003-4503-3108
Ariadne LetraDepartments of Oral and Craniofacial Sciences, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA 15260, USA.ORCID 0000-0002-7197-6735
Renato M SilvaDepartments of Oral and Craniofacial Sciences, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA 15260, USA.
Alexandre R VieiraDepartments of Oral and Craniofacial Sciences, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA 15260, USA.ORCID 0000-0003-3392-6881
Franz J StraussClinic of Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, 8006 Zurich, Switzerland.
Gustavo P GarletBauru School of Dentistry, University of Sao Paulo, Bauru 14040-902, Brazil.ORCID 0000-0002-5071-8382

Funding

FAPESP 2014/03276-0
6 · The paper itself

Abstract

Periodontitis is a multifactorial disease linked to host immune response and genetic predisposition. The TLR4 Asp299Gly single-nucleotide polymorphism (SNP, rs4986790) has been associated with altered responses to bacterial lipopolysaccharide (LPS) and may influence susceptibility to inflammatory diseases. Given the central role of TLR4 in innate immune recognition of periodontal pathogens, this study investigates the role of rs4986790 in modulating susceptibility to periodontal inflammatory destruction. A total of 1410 individuals from four populations were genotyped, with findings indicating a significant protective effect of the polymorphic allele. Functional assays demonstrated enhanced IL-8 secretion and increased sensitivity to CD14 inhibition in cells expressing the variant receptor. These results suggest that rs4986790 modifies the LPS response via TLR4, potentially offering protection against periodontal breakdown.

Indexed as

IL-8immune responseinflammationLPSperiodontitisrs4986790SNPTLR4

Identifiers

PMID40723451
PMCPMC12292776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.